Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.
about
Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritisThe Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid ArthritisImmunopathology of synovitis: from histology to molecular pathwaysDecrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic RatsResponse to rituximab in patients with rheumatoid arthritis in different compartments of the immune system.Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapyThe features of the synovium in early rheumatoid arthritis according to the 2010 ACR/EULAR classification criteriaFrom synovial tissue to peripheral blood: myeloid related protein 8/14 is a sensitive biomarker for effective treatment in early drug development in patients with rheumatoid arthritisExpression of Prostaglandin E2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis PatientsMacrophage plasticity and polarization: in vivo veritasEvaluation of arthroscopy and macroscopic scoring.Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohortData on sulforaphane treatment mediated suppression of autoreactive, inflammatory M1 macrophages.Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.Monocyte scintigraphy in rheumatoid arthritis: the dynamics of monocyte migration in immune-mediated inflammatory disease.B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers.Synovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross-sectional study.Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages.Utility of arthroscopic guided synovial biopsy in understanding synovial tissue pathology in health and disease statesCharacterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K/BxN mouseIdentification and evaluation of novel synovial tissue biomarkers in rheumatoid arthritis by laser scanning cytometry.Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation.Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritisAnti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation.Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumabThe relative composition of the inflammatory infiltrate as an additional tool for synovial tissue classification.Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate.Mononuclear Phagocytes in Rheumatoid Arthritis Patients and their Relatives - Family SimilaritySynovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritisPretreatment macrophage infiltration of the synovium predicts the clinical effect of both radiation synovectomy and intra-articular glucocorticoidsSynovial Tissue Response to Treatment with TNF Blockers in Peripheral SpondyloarthritisReal-time quantitative PCR to detect changes in synovial gene expression in rheumatoid arthritis after corticosteroid treatment.A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm.Is there a role of synovial biopsy in drug development?Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment.Assessment of synovitis to predict bone erosions in rheumatoid arthritis.Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis.Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis
P2860
Q24817151-4A5DC634-6C1C-4AEC-9B27-78214CA86DAAQ26774681-7F195861-3329-4703-B72A-6C0C9E23E314Q26781647-CA8F0E25-5B5E-4E7F-9B3A-7F16E7458400Q27345563-217480AB-D993-4CA3-B795-B759FA8D73F1Q27692640-1C36CBE4-D013-49B4-8CEF-B04CAD57BE78Q28084913-5C831566-8908-4A12-AF5A-B5B48C71110CQ28483442-37C6F983-3824-45E1-90E3-C4A1DDA7BB4FQ28542641-48ADB325-23DF-4336-9B0F-7B811FCF9327Q28546899-A9E6746B-DE74-4F74-803C-80839C1BF763Q29547620-457BCDFB-0C6A-474E-BA5A-B1749AB8FB0EQ30488975-17777624-F40C-4AD3-96F0-CDB2689B22B5Q30839061-F48612E5-3208-4A6F-845E-35BB003C6EE1Q31101624-3AB5A445-A654-4C8F-9E81-ADED0F3485C3Q33390403-1A3FE263-6B65-48C2-A405-3106DD4075B9Q33516229-EE8C0E62-3C24-4545-BB3D-A8BCF5E67CD7Q33616360-E2E2540D-DDB0-43EC-A07A-1231CDC66442Q33832629-88E939EB-EB13-4180-9D00-075225F6DBD2Q33892422-12B1A575-9372-40F8-861C-87BC45AA09C4Q34047769-1838A311-9C73-4E7E-8CB2-9B9F8B927880Q34086970-2F3288D2-C106-45B5-A7B9-83B58D7AA116Q34129396-725FD384-1036-456D-A21E-1C6DC58BF2A2Q34153125-88C223CC-FACB-4471-84A7-1A344294D3C8Q34317197-03569C1C-37FD-45DE-B8CC-F3DE194A71A4Q34608852-0D9DA12C-9D00-44A0-98DD-BF468648D5A8Q34906120-DC015F57-EDE4-4A34-9253-CC53C606ABC5Q34951693-7696BD76-3215-455E-8B75-DC34FBBB4D3BQ35092982-7CD041EF-C895-40CF-8296-936ED7CD7C9AQ35560797-96D69B98-E5C9-44D6-B0F7-9D579B8E07FDQ35637474-CE5BA8D7-2EB9-4CDA-BE2D-E87061A97B02Q35638030-FE5CA024-BCF4-46E2-9322-1A0C09A0BBBBQ35687019-D9B2CCEC-02B3-440B-9717-02148E5AC2C6Q35760103-2E58933D-F7DD-4B90-A95E-CC39C3F27C73Q35835741-6889D2B7-8B90-49C1-AA01-BF16056D9433Q35994130-76CBC2A5-3D44-400B-BC1F-ABE51F45AC42Q36014211-54798BB3-4790-4034-B14B-BCC9450ECEDAQ36111299-11C59835-A054-466E-98B6-DEBB02F141ADQ36148660-431E4524-0807-4F81-BEAC-93878E7CE0E1Q36150157-A3FB79BC-A270-462C-8E78-9BEDA67FC53EQ36173601-371E0BD8-7F2C-4B55-BDFB-762E0397ED6FQ36245798-8D038DDA-4A9E-4E86-A975-AF589CB5F54D
P2860
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Synovial tissue macrophages: a ...... nts with rheumatoid arthritis.
@en
Synovial tissue macrophages: a ...... nts with rheumatoid arthritis.
@nl
type
label
Synovial tissue macrophages: a ...... nts with rheumatoid arthritis.
@en
Synovial tissue macrophages: a ...... nts with rheumatoid arthritis.
@nl
prefLabel
Synovial tissue macrophages: a ...... nts with rheumatoid arthritis.
@en
Synovial tissue macrophages: a ...... nts with rheumatoid arthritis.
@nl
P2093
P2860
P921
P356
P1476
Synovial tissue macrophages: a ...... nts with rheumatoid arthritis.
@en
P2093
Bresnihan B
Haringman JJ
McInnes IB
Zwinderman AH
P2860
P304
P356
10.1136/ARD.2004.029751
P407
P577
2004-12-02T00:00:00Z